Systemic IgG Exposure and Safety in Patients with Primary Immunodeficiency: A Randomized Crossover Study Comparing a Novel Investigational Wearable Infusor Versus the Crono Pump
Open Access
- 21 September 2022
- journal article
- research article
- Published by Taylor & Francis in Immunotherapy
- Vol. 14 (16) , 1315-1328
Abstract
Aim: A novel, Investigational Wearable Infusor (IWI) was evaluated in a randomized, controlled, crossover, open-label study to determine if its delivery of subcutaneous immunoglobulin (IgPro20) ach... Plain language summary Patients with primary immunodeficiency (PID) are at a higher risk of developing serious infections than healthy individuals. Immunoglobulin G (IgG) replacement therapy reduce...Keywords
Funding Information
- CSL Behring
- National Institutes of Health (AI-061093, AI-086037, AI-48693)
This publication has 22 references indexed in Scilit:
- Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapyClinical and Experimental Immunology, 2012
- Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapyClinical Immunology, 2011
- Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary ImmunodeficiencyClinical Pharmacokinetics, 2011
- Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studiesClinical Immunology, 2010
- Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary ImmunodeficiencyJournal of Clinical Immunology, 2010
- Subcutaneous Administration of IgGImmunology and Allergy Clinics of North America, 2008
- Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary ImmunodeficienciesJournal of Clinical Immunology, 2008
- Health-Related Quality of Life and Treatment Satisfaction in North American Patients with Primary Immunedeficiency Diseases Receiving Subcutaneous IgG Self-Infusions at HomeJournal of Clinical Immunology, 2006
- Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at homeJournal of Allergy and Clinical Immunology, 2004
- Subcutaneous immunoglobulin replacement in primary immunodeficienciesClinical Immunology, 2004